Hyperspectral imaging of glucose uptake, mitochondrial membrane potential, and vascular oxygenation differentiates breast cancers with distinct metastatic potential in vivo

Published

Conference Paper

© OSA 2016. We performed in vivo hyperspectral imaging in a preclinical cancer model to capture key metabolic endpoints (glucose uptake, mitochondrial membrane potential, and vascular oxygenation) to successfully distinguish metastatic and non-metastatic tumors.

Full Text

Duke Authors

Cited Authors

  • Martinez, AF; McCachren, SS; Lee, M; Murphy, HA; Rajaram, N; Dewhirst, MW; Ramanujam, N

Published Date

  • July 21, 2014

Published In

  • Optics Infobase Conference Papers

International Standard Book Number 13 (ISBN-13)

  • 9781943580101

Digital Object Identifier (DOI)

  • 10.1364/CANCER.2016.CTh4A.6

Citation Source

  • Scopus